Joe Kimanthi Mutungi

Dr. Joe Kimanthi Mutungi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
YPYu Pang
Yu Pang
HYHayashi Yamamoto
Hayashi Yamamoto
HSHirokazu Sakamoto
Hirokazu Sakamoto
MOMasahide Oku
Masahide Oku
JMJoe Kimanthi Mutungi
Joe Kimanthi Mutungi
NMNoboru Mizushima
Noboru Mizushima

16 December 2020 in Experimental Biology and Medicine
Verified
Journal Article
Open access
PDF file
JNJoyce M Ngoi
Joyce M Ngoi
PQPeter Kojo Quashie
Peter Kojo Quashie
CMCollins M Morang'A
Collins M Morang'A
JBJoseph Hk Bonney
Joseph Hk Bonney
DADominic Selorm Yao Amuzu
Dominic Selorm Yao Amuzu
GAGordon A. Awandare
Gordon A. Awandare
The confirmed case fatality rate for the coronavirus disease 2019 (COVID-19) in Ghana has dropped from a peak of 2% in March to be consistently below 1% since May 2020. Globally, case fatality rates have been linked to the strains/clades of circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within a specific country. Here we present 46 whole genomes of SARS-CoV-2 circulating in Ghana, from two separate sequencing batches: 15 isolates from the early epidemic (March 12–April 1 2020) and 31 from later time-points ( 25–27 May 2020). Sequencing was carried out on an Illumina MiSeq system following an amplicon-based enrichment for SARS-CoV-2 cDNA. After genome assembly and quality control processes, phylogenetic analysis showed that the first batch of 15 genomes clustered into five clades: 19A, 19B, 20A, 20B, and 20C, whereas the second batch of 31 genomes clustered to only three clades 19B, 20A, and 20B. The imported cases (6/46) mapped to circulating viruses in their countries of origin, namely, India, Hungary, Norway, the United Kingdom, and the United States of America. All genomes mapped to the original Wuhan strain with high similarity (99.5–99.8%). All imported strains mapped to the European superclade A, whereas 5/9 locally infected individuals harbored the B4 clade, from the East Asian superclade B. Ghana appears to have 19B and 20B as the two largest circulating clades based on our sequence analyses. In line with global reports, the D614G linked viruses seem to be predominating. Comparison of Ghanaian SARS-CoV-2 genomes with global genomes indicates that Ghanaian strains have not diverged significantly from circulating strains commonly imported into Africa. The low level of diversity in our genomes may indicate lower levels of transmission, even for D614G viruses, which is consistent with the relatively low levels of infection reported in Ghana.

6 July 2021 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
PQPeter Kojo Quashie
Peter Kojo Quashie
JMJoe Kimanthi Mutungi
Joe Kimanthi Mutungi
FDFrancis Dzabeng
Francis Dzabeng
DODaniel Oduro-Mensah
Daniel Oduro-Mensah
POPrecious C. Opurum
Precious C. Opurum
GAGordon A. Awandare
Gordon A. Awandare
Background : We set out to estimate the community-level exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods : Phased seroprevalence studies of 2729 participants at selected locations across Ghana were conducted. Phase I (August 2020) sampled 1305 individuals at major markets/lorry stations, shopping malls, hospitals and research institutions involved in coronavirus disease 2019 (COVID-19) work. The study utilized a lateral flow rapid diagnostic test (RDT) which detected IgM and IgG antibodies against SARS-CoV-2 nucleocapsid protein. Results : During Phase I, 252/1305 (19%) tested positive for IgM or IgG or both. Exposure was significantly higher at markets/lorry stations (26.9%) compared to malls (9.4%), with 41–60-year group demonstrating highest seropositivity (27.2%). Exposure was higher in participants with no formal education (26.2%) than those with tertiary education (13.1%); and higher in informally employed workers (24.0%) than those in the formal sector (15.0%). Results from phases II and III, in October and December 2020 respectively, implied either reduced transmissions or loss of antibody expression in some participants. The Upper East region showed the lowest seropositivity (2%). Phase IV, in February 2021, showed doubled seropositivity in the upper income bracket (26.2%) since August 2020, reflective of Ghana’s second wave of symptomatic COVID-19 cases. This suggested that high transmission rates had overcome the initial socioeconomic stratification of exposure risk. Reflective of second wave hospitalisation trends, the 21-40 age group demonstrated modal seropositivity (24.9) in Phase IV whilst 40-60 years and 60+ previously demonstrated highest prevalence. Conclusions : Overall, the data indicates higher COVID-19 seroprevalence than officially acknowledged, likely implying a considerably lower-case fatality rate than the current national figure of 0.84%. The data also suggests that COVID-19 is predominantly asymptomatic COVID-19 in Ghana. The observed trends mimic clinical trends of infection and imply that the methodology used was appropriate.

1 December 2014 in Parasitology International
Verified
Journal Article
Closed access
JMJoe Kimanthi Mutungi
Joe Kimanthi Mutungi
KYKazuhide Yahata
Kazuhide Yahata
MSMiako Sakaguchi
Miako Sakaguchi
OKOsamu Kaneko
Osamu Kaneko

1 November 2015 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
JMJoe Kimanthi Mutungi
Joe Kimanthi Mutungi
KYKazuhide Yahata
Kazuhide Yahata
MSMiako Sakaguchi
Miako Sakaguchi
OKOsamu Kaneko
Osamu Kaneko

4 February 2022 in Open Research Africa
Verified
Journal Article
Open access
PDF file
MKMoses Kamita
Moses Kamita
JMJoe Kimanthi Mutungi
Joe Kimanthi Mutungi
SMSamuel Mungai
Samuel Mungai
DMDominic Mureithi
Dominic Mureithi
CKCaroline Kijogi
Caroline Kijogi
JGJesse Gitaka
Jesse Gitaka
Background Antibiotic resistance is a growing global health threat worldwide and especially in developing countries. Irrational antibiotic prescription as well as lack of the requisite knowledge and awareness of proper antibiotic use are major drivers of antibiotic resistance. In Kenya, although the Ministry of Health has developed antibiotic use guidelines, these guidelines are not widely followed. Antibiotic prescription is, therefore, hugely at the discretion of the clinician. It is thus necessary to understand the knowledge, attitude, and practices (KAP) of antibiotic prescription among medical practitioners in the country. This study aimed to evaluate the knowledge, attitude, and practices (KAP) among antibiotic prescribers in three counties (Kiambu, Nakuru, and Bungoma) in Kenya. Methods This was a cross-sectional study using a self-administered questionnaire. Simple descriptive statistics were used to generate frequencies, percentages, and proportions. Where necessary, univariate analyses such as Pearson’s chi-square were performed to compare proportions for statistical significance. Results From the three counties, 240 respondents recorded their responses: 30% from Kiambu, 34.6% from Nakuru, and 35.4% from Bungoma. The respondents included 19 (7.9%) consultants, 66 (27.4%) medical officers, 135 (56.3%) clinical officers and 20 (8.3%) pharmacists. Of all respondents, more than 90% agreed or strongly agreed that antibiotic resistance (ABR) is a catastrophe worldwide and in Kenya. However, the proportion of the respondents who either agreed or strongly agreed (71.6%) that antibiotic resistance is a problem in their respective health facilities was significantly lower (ρ=0.013). Conclusion This study revealed that most medical practitioners were aware and knowledgeable about antibiotic resistance. However, there was a disconnect with mitigation measures such as active antibiotic stewardship and laboratory analyses to support judicious prescription. There is, therefore, a need for continuous education and stewardship interventions.